サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1291422

放射性皮膚炎市場：世界の産業動向、シェア、規模、成長機会、2023-2028年予測

Radiodermatitis Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
出版日: | 発行: IMARC | ページ情報: 英文 144 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
放射性皮膚炎市場：世界の産業動向、シェア、規模、成長機会、2023-2028年予測
出版日: 2023年05月29日
発行: IMARC
ページ情報: 英文 144 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

市場概要：

世界の放射性皮膚炎の市場規模は、2022年に4億8,190万米ドルに達しました。今後、IMARC Groupは、2023年から2028年の間に3.5%の成長率（CAGR）を示し、2028年までに5億9,790万米ドルに達すると予想しています。

放射性皮膚炎（Radiodermatitis）とは、がんの治療に用いられる放射線療法によって引き起こされる皮膚症状のことを指します。一般に、乳房、肺、皮膚、頸部、頭部、会陰部などのガン患者において、がん治療中やインターベンショナル・ラジオロジー後に副作用として発生し、皮膚が標的領域の一部となります。放射性皮膚炎を治療するために一般的に使用される製品には、局所抗生物質、コルチコステロイド、親水性クリーム、ヒドロゲルおよびヒドロコロイドドレッシング、シリコーンコーテッドドレッシング、銀葉ドレッシング、経口鎮痛剤、抗炎症剤などがあります。近年、放射性皮膚炎治療は、不快感を軽減し、痛みを最小限に抑え、患者の生活全体の質を向上させながら、継続的な治療の中断を防ぐことができるため、支持を集めています。

放射性皮膚炎の市場動向：

がんの蔓延と治療法としての放射線治療の普及が、市場の成長を促進する主な要因となっています。また、世界の老人人口の増加や、放射線治療の副作用対策へのニーズの高まりが、放射性皮膚炎治療への需要を高めています。さらに、多くの政府機関や非政府機関が、利用可能な放射性皮膚炎治療・管理製品に関する認識を広めるために、好ましい取り組みを行っています。これは、ライフサイエンス分野における研究開発活動への公的・私的投資の増加と相まって、市場の成長を促進する要因となっています。さらに、大手企業は製品ポートフォリオを拡大し、競争力を高めるために、革新的な製品バリエーションの開発に注力しています。さらに、臨床試験件数の増加、有利な政府政策、消費者支出の増加、ヘルスケアインフラの改善、ジェネリック医薬品の入手の容易さなども、市場の見通しを明るくしている要因のひとつです。

本レポートで回答した主な質問

  • 2022年の世界の放射性皮膚炎市場の規模は？
  • 2023年～2028年の世界の放射性皮膚炎市場の予想成長率はどのくらいか？
  • COVID-19が世界の放射性皮膚炎市場に与えた影響は？
  • 世界の放射性皮膚炎市場を牽引する主要因は何か？
  • 放射性皮膚炎の世界市場の製品別区分は？
  • 放射性皮膚炎の世界市場の流通経路に基づく区分は？
  • 放射性皮膚炎の世界市場における主要地域はどこか？
  • 放射性皮膚炎の世界市場における主要企業は？

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査目的
  • 利害関係者
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 予測手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要産業動向

第5章 放射性皮膚炎の世界市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 製品別市場内訳

  • トピック
    • 市場動向
    • 主要セグメント
      • 副腎皮質ホルモン剤
      • 親水性クリーム
      • 抗生物質
      • その他
    • 市場予測
  • 経口
    • 市場動向
    • 市場予測
  • ドレッシング
    • 市場動向
    • 主要セグメント
      • ハイドロゲルとハイドロコロイドのドレッシング
      • ノースティングバリアフィルム
      • ハチミツ入りガーゼ
      • シリコーン被覆ドレッシング
      • その他
    • 市場予測

第7章 流通チャネル別市場内訳

  • 病院薬局
    • 市場動向
    • 市場予測
  • 調剤薬局
    • 市場動向
    • 市場予測
  • オンライン薬局
    • 市場動向
    • 市場予測

第8章 地域別市場内訳

  • 北米
    • 米国
      • 市場動向
      • 市場予測
    • カナダ
      • 市場動向
      • 市場予測
  • アジア太平洋地域
    • 中国
      • 市場動向
      • 市場予測
    • 日本
      • 市場動向
      • 市場予測
    • インド
      • 市場動向
      • 市場予測
    • 韓国
      • 市場動向
      • 市場予測
    • オーストラリア
      • 市場動向
      • 市場予測
    • インドネシア
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • 欧州
    • ドイツ
      • 市場動向
      • 市場予測
    • フランス
      • 市場動向
      • 市場予測
    • 英国
      • 市場動向
      • 市場予測
    • イタリア
      • 市場動向
      • 市場予測
    • スペイン
      • 市場動向
      • 市場予測
    • ロシア
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • ラテンアメリカ
    • ブラジル
      • 市場動向
      • 市場予測
    • メキシコ
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • 中東・アフリカ地域
    • 市場動向
    • 国別市場内訳
    • 市場予測

第9章 SWOT分析

  • 概要
  • 強み
  • 弱み
  • 機会
  • 脅威

第10章 バリューチェーン分析

第11章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の度合い
  • 新規参入業者の脅威
  • 代替品の脅威

第12章 価格分析

第13章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • 3M Company
    • Bausch Health Companies Inc.
    • Bayer AG
    • BMG PHARMA S.p.A.
    • Charles River Laboratories International Inc.
    • ConvaTec Group plc
    • Helsinn Healthcare SA
    • ICON plc
    • Integra LifeSciences
    • Molnlycke Health Care AB
    • Stratpharma AG
図表

List of Figures

  • Figure 1: Global: Radiodermatitis Market: Major Drivers and Challenges
  • Figure 2: Global: Radiodermatitis Market: Sales Value (in Million US$), 2017-2022
  • Figure 3: Global: Radiodermatitis Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 4: Global: Radiodermatitis Market: Breakup by Product (in %), 2022
  • Figure 5: Global: Radiodermatitis Market: Breakup by Distribution Channel (in %), 2022
  • Figure 6: Global: Radiodermatitis Market: Breakup by Region (in %), 2022
  • Figure 7: Global: Radiodermatitis (Topical) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 8: Global: Radiodermatitis (Topical) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 9: Global: Radiodermatitis (Oral) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 10: Global: Radiodermatitis (Oral) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 11: Global: Radiodermatitis (Dressings) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 12: Global: Radiodermatitis (Dressings) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 13: Global: Radiodermatitis (Hospital Pharmacy) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 14: Global: Radiodermatitis (Hospital Pharmacy) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 15: Global: Radiodermatitis (Retail Pharmacy) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 16: Global: Radiodermatitis (Retail Pharmacy) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 17: Global: Radiodermatitis (Online Pharmacy) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 18: Global: Radiodermatitis (Online Pharmacy) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 19: North America: Radiodermatitis Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 20: North America: Radiodermatitis Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 21: United States: Radiodermatitis Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 22: United States: Radiodermatitis Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 23: Canada: Radiodermatitis Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 24: Canada: Radiodermatitis Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 25: Asia-Pacific: Radiodermatitis Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 26: Asia-Pacific: Radiodermatitis Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 27: China: Radiodermatitis Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 28: China: Radiodermatitis Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 29: Japan: Radiodermatitis Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 30: Japan: Radiodermatitis Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 31: India: Radiodermatitis Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 32: India: Radiodermatitis Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 33: South Korea: Radiodermatitis Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 34: South Korea: Radiodermatitis Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 35: Australia: Radiodermatitis Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 36: Australia: Radiodermatitis Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 37: Indonesia: Radiodermatitis Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 38: Indonesia: Radiodermatitis Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 39: Others: Radiodermatitis Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 40: Others: Radiodermatitis Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 41: Europe: Radiodermatitis Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 42: Europe: Radiodermatitis Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 43: Germany: Radiodermatitis Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 44: Germany: Radiodermatitis Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 45: France: Radiodermatitis Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 46: France: Radiodermatitis Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 47: United Kingdom: Radiodermatitis Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 48: United Kingdom: Radiodermatitis Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 49: Italy: Radiodermatitis Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 50: Italy: Radiodermatitis Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 51: Spain: Radiodermatitis Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 52: Spain: Radiodermatitis Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 53: Russia: Radiodermatitis Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 54: Russia: Radiodermatitis Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 55: Others: Radiodermatitis Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 56: Others: Radiodermatitis Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 57: Latin America: Radiodermatitis Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 58: Latin America: Radiodermatitis Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 59: Brazil: Radiodermatitis Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 60: Brazil: Radiodermatitis Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 61: Mexico: Radiodermatitis Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 62: Mexico: Radiodermatitis Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 63: Others: Radiodermatitis Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 64: Others: Radiodermatitis Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 65: Middle East and Africa: Radiodermatitis Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 66: Middle East and Africa: Radiodermatitis Market: Breakup by Country (in %), 2022
  • Figure 67: Middle East and Africa: Radiodermatitis Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 68: Global: Radiodermatitis Industry: SWOT Analysis
  • Figure 69: Global: Radiodermatitis Industry: Value Chain Analysis
  • Figure 70: Global: Radiodermatitis Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Radiodermatitis Market: Key Industry Highlights, 2022 and 2028
  • Table 2: Global: Radiodermatitis Market Forecast: Breakup by Product (in Million US$), 2023-2028
  • Table 3: Global: Radiodermatitis Market Forecast: Breakup by Distribution Channel (in Million US$), 2023-2028
  • Table 4: Global: Radiodermatitis Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 5: Global: Radiodermatitis Market: Competitive Structure
  • Table 6: Global: Radiodermatitis Market: Key Players
目次
Product Code: SR112023A5638

Market Overview:

The global radiodermatitis market size reached US$ 481.9 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 597.9 Million by 2028, exhibiting a growth rate (CAGR) of 3.5% during 2023-2028.

Radiodermatitis, or radiation dermatitis, refers to a skin condition caused due to radiation therapy used for the treatment of cancer. It generally occurs as a side effect during cancer treatment or after interventional radiology in patients with cancers of the breast, lungs, skin, neck, head or perineum region where the skin is part of the target field. Some of the commonly used products to treat radiodermatitis include topical antibiotics, corticosteroids, hydrophilic creams, hydrogel and hydrocolloid dressings, silicone-coated dressings, silver-leaf dressings, oral analgesics, and anti-inflammatory agents. In recent years, radiodermatitis treatment has gained traction as it helps reduce discomfort, minimize pain and prevent interruption in ongoing therapy while improving the overall quality of the patient's life. 

Radiodermatitis Market Trends:

The widespread prevalence of cancer and the rising adoption of radiation therapy as a treatment option represent the primary factors driving the market growth. Besides this, the increasing geriatric population across the globe and the growing need to counter the adverse side effects of radiation therapy are augmenting the demand for radiodermatitis treatment. Additionally, numerous governing and non-governing agencies are taking favorable initiatives to spread awareness regarding the available radiodermatitis treatment and management products. This, in confluence with the rising public and private investments in the ongoing research and development (R&D) activities in the field of life sciences, is catalyzing the market growth. Furthermore, the leading players are focusing on developing innovative product variants to expand their product portfolio and gain a competitive edge. Moreover, the rising number of clinical trials, favorable government policies, increasing consumer expenditure capacities, improving healthcare infrastructure and easy availability of generic drugs are some of the other factors creating a positive market outlook.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global radiodermatitis market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on product and distribution channel.

Breakup by Product:

  • Topical
    • Corticosteroids
    • Hydrophilic Creams
    • Antibiotics
    • Others
  • Oral
  • Dressings
    • Hydrogel and Hydrocolloid Dressings
    • No Sting Barrier Film
    • Honey Impregnated Gauze
    • Silicone Coated Dressings
    • Others

Breakup by Distribution Channel:

  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being 3M Company, Bausch Health Companies Inc., Bayer AG, BMG PHARMA S.p.A., Charles River Laboratories International Inc., ConvaTec Group plc, Helsinn Healthcare SA, ICON plc, Integra LifeSciences, Molnlycke Health Care AB and Stratpharma AG.

Key Questions Answered in This Report:

  • What was the size of the global radiodermatitis market in 2022?
  • What is the expected growth rate of the global radiodermatitis market during 2023-2028?
  • What has been the impact of COVID-19 on the global radiodermatitis market?
  • What are the key factors driving the global radiodermatitis market?
  • What is the breakup of the global radiodermatitis market based on the product?
  • What is the breakup of the global radiodermatitis market based on the distribution channel?
  • What are the key regions in the global radiodermatitis market?
  • Who are the key players/companies in the global radiodermatitis market?

Table of Contents

1   Preface

2   Scope and Methodology

  • 2.1  Objectives of the Study
  • 2.2  Stakeholders
  • 2.3  Data Sources
    • 2.3.1  Primary Sources
    • 2.3.2  Secondary Sources
  • 2.4  Market Estimation
    • 2.4.1  Bottom-Up Approach
    • 2.4.2  Top-Down Approach
  • 2.5  Forecasting Methodology

3   Executive Summary

4   Introduction

  • 4.1  Overview
  • 4.2  Key Industry Trends

5   Global Radiodermatitis Market

  • 5.1  Market Overview
  • 5.2  Market Performance
  • 5.3  Impact of COVID-19
  • 5.4  Market Forecast

6   Market Breakup by Product

  • 6.1  Topical
    • 6.1.1 Market Trends
    • 6.1.2 Key Segments
      • 6.1.2.1 Corticosteroids
      • 6.1.2.2 Hydrophilic Creams
      • 6.1.2.3 Antibiotics
      • 6.1.2.4 Others
    • 6.1.3 Market Forecast
  • 6.2  Oral
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3  Dressings
    • 6.3.1 Market Trends
    • 6.3.2 Key Segments
      • 6.3.2.1 Hydrogel and Hydrocolloid Dressings
      • 6.3.2.2 No Sting Barrier Film
      • 6.3.2.3 Honey Impregnated Gauze
      • 6.3.2.4 Silicone Coated Dressings
      • 6.3.2.5 Others
    • 6.3.3 Market Forecast

7   Market Breakup by Distribution Channel

  • 7.1  Hospital Pharmacy
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2  Retail Pharmacy
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3  Online Pharmacy
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8   Market Breakup by Region

  • 8.1  North America
    • 8.1.1 United States
      • 8.1.1.1 Market Trends
      • 8.1.1.2 Market Forecast
    • 8.1.2 Canada
      • 8.1.2.1 Market Trends
      • 8.1.2.2 Market Forecast
  • 8.2  Asia-Pacific
    • 8.2.1 China
      • 8.2.1.1 Market Trends
      • 8.2.1.2 Market Forecast
    • 8.2.2 Japan
      • 8.2.2.1 Market Trends
      • 8.2.2.2 Market Forecast
    • 8.2.3 India
      • 8.2.3.1 Market Trends
      • 8.2.3.2 Market Forecast
    • 8.2.4 South Korea
      • 8.2.4.1 Market Trends
      • 8.2.4.2 Market Forecast
    • 8.2.5 Australia
      • 8.2.5.1 Market Trends
      • 8.2.5.2 Market Forecast
    • 8.2.6 Indonesia
      • 8.2.6.1 Market Trends
      • 8.2.6.2 Market Forecast
    • 8.2.7 Others
      • 8.2.7.1 Market Trends
      • 8.2.7.2 Market Forecast
  • 8.3  Europe
    • 8.3.1 Germany
      • 8.3.1.1 Market Trends
      • 8.3.1.2 Market Forecast
    • 8.3.2 France
      • 8.3.2.1 Market Trends
      • 8.3.2.2 Market Forecast
    • 8.3.3 United Kingdom
      • 8.3.3.1 Market Trends
      • 8.3.3.2 Market Forecast
    • 8.3.4 Italy
      • 8.3.4.1 Market Trends
      • 8.3.4.2 Market Forecast
    • 8.3.5 Spain
      • 8.3.5.1 Market Trends
      • 8.3.5.2 Market Forecast
    • 8.3.6 Russia
      • 8.3.6.1 Market Trends
      • 8.3.6.2 Market Forecast
    • 8.3.7 Others
      • 8.3.7.1 Market Trends
      • 8.3.7.2 Market Forecast
  • 8.4  Latin America
    • 8.4.1 Brazil
      • 8.4.1.1 Market Trends
      • 8.4.1.2 Market Forecast
    • 8.4.2 Mexico
      • 8.4.2.1 Market Trends
      • 8.4.2.2 Market Forecast
    • 8.4.3 Others
      • 8.4.3.1 Market Trends
      • 8.4.3.2 Market Forecast
  • 8.5  Middle East and Africa
    • 8.5.1 Market Trends
    • 8.5.2 Market Breakup by Country
    • 8.5.3 Market Forecast

9   SWOT Analysis

  • 9.1  Overview
  • 9.2  Strengths
  • 9.3  Weaknesses
  • 9.4  Opportunities
  • 9.5  Threats

10  Value Chain Analysis

11  Porters Five Forces Analysis

  • 11.1  Overview
  • 11.2  Bargaining Power of Buyers
  • 11.3  Bargaining Power of Suppliers
  • 11.4  Degree of Competition
  • 11.5  Threat of New Entrants
  • 11.6  Threat of Substitutes

12  Price Analysis

13  Competitive Landscape

  • 13.1  Market Structure
  • 13.2  Key Players
  • 13.3  Profiles of Key Players
    • 13.3.1  3M Company
      • 13.3.1.1 Company Overview
      • 13.3.1.2 Product Portfolio
      • 13.3.1.3 Financials
      • 13.3.1.4 SWOT Analysis
    • 13.3.2  Bausch Health Companies Inc.
      • 13.3.2.1 Company Overview
      • 13.3.2.2 Product Portfolio
      • 13.3.2.3 Financials
      • 13.3.2.4 SWOT Analysis
    • 13.3.3  Bayer AG
      • 13.3.3.1 Company Overview
      • 13.3.3.2 Product Portfolio
      • 13.3.3.3 Financials
      • 13.3.3.4 SWOT Analysis
    • 13.3.4  BMG PHARMA S.p.A.
      • 13.3.4.1 Company Overview
      • 13.3.4.2 Product Portfolio
    • 13.3.5  Charles River Laboratories International Inc.
      • 13.3.5.1 Company Overview
      • 13.3.5.2 Product Portfolio
      • 13.3.5.3 Financials
      • 13.3.5.4 SWOT Analysis
    • 13.3.6  ConvaTec Group plc
      • 13.3.6.1 Company Overview
      • 13.3.6.2 Product Portfolio
      • 13.3.6.3 Financials
    • 13.3.7  Helsinn Healthcare SA
      • 13.3.7.1 Company Overview
      • 13.3.7.2 Product Portfolio
    • 13.3.8  ICON plc
      • 13.3.8.1 Company Overview
      • 13.3.8.2 Product Portfolio
      • 13.3.8.3 Financials
      • 13.3.8.4 SWOT Analysis
    • 13.3.9  Integra LifeSciences
      • 13.3.9.1 Company Overview
      • 13.3.9.2 Product Portfolio
      • 13.3.9.3 Financials
      • 13.3.9.4 SWOT Analysis
    • 13.3.10  Molnlycke Health Care AB
      • 13.3.10.1 Company Overview
      • 13.3.10.2 Product Portfolio
      • 13.3.10.3 SWOT Analysis
    • 13.3.11  Stratpharma AG
      • 13.3.11.1 Company Overview
      • 13.3.11.2 Product Portfolio